Found 3687 matching trials
Ketogenic Diet as Protective Factor During COVID-19
NAThe novel coronavirus disease (COVID-19) is posing a serious challenge to t...
Location
Ospedale San Bortolo
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
PHASE2This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
N/AThe primary objective of the study is to evaluate the adherence to the trea...
Location
Multiple Locations
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
PHASE2The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Location
Emory University Winship Cancer Institute
Blood Purification in Patients With Septic Shock
NAIn recent years, many studies have pointed out that bacterial toxin storm a...
Location
National Taiwan University Hospital
A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma
PHASE11. To demonstrate the feasibility of leukapheresis and ex vivo activation o...
Location
National University Hospital
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer
PHASE2This is a phase II Randomized comparison clinical trial of activated CIK ar...
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
PHASE2This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Location
M D Anderson Cancer Center
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer
PHASE2In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Location
University of Texas Southwestern Medical Center
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
PHASE1The purpose of this study is to find the number of natural killer (NK) cell...
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center